166 related articles for article (PubMed ID: 1376812)
1. Antihypertensive effect of lisinopril assessed by 24-hour ambulatory monitoring: a double-blind, placebo-controlled, cross-over study.
Tomei R; Rossi L; Carbonieri E; Franceschini L; Molon G; Zardini P
J Cardiovasc Pharmacol; 1992 Jun; 19(6):911-4. PubMed ID: 1376812
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
[TBL] [Abstract][Full Text] [Related]
3. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
4. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
Motero Carrasco J
Arch Inst Cardiol Mex; 1997; 67(1):29-37. PubMed ID: 9221708
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
[TBL] [Abstract][Full Text] [Related]
6. Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors.
White WB; Kent J; Taylor A; Verburg KM; Lefkowith JB; Whelton A
Hypertension; 2002 Apr; 39(4):929-34. PubMed ID: 11967252
[TBL] [Abstract][Full Text] [Related]
7. Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group.
Weir MR; Reisin E; Falkner B; Hutchinson HG; Sha L; Tuck ML
Am J Hypertens; 1998 Aug; 11(8 Pt 1):914-20. PubMed ID: 9715782
[TBL] [Abstract][Full Text] [Related]
8. Assessment of antihypertensive effect by blood pressure monitoring: applications to bisoprolol and lisinopril in a double-blind study.
Vaïsse B; Herpin D; Asmar R; Battistella P; Zannad F; Boutelant S; Lyon A; Conte D; Denis J; Honore P; Contard S; Prost PL; Mallion JM; Poggi L
J Cardiovasc Pharmacol; 1997 May; 29(5):612-7. PubMed ID: 9213203
[TBL] [Abstract][Full Text] [Related]
9. Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring.
Diamant M; Vincent HH
J Hum Hypertens; 1999 Jun; 13(6):405-12. PubMed ID: 10408591
[TBL] [Abstract][Full Text] [Related]
10. Lisinopril dose-response relationship in essential hypertension.
Gomez HJ; Cirillo VJ; Sromovsky JA; Otterbein ES; Shaw WC; Rush JE; Chrysant SG; Gradman AH; Leon AS; MacCarthy EP
Br J Clin Pharmacol; 1989 Oct; 28(4):415-20. PubMed ID: 2556172
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
Lacourcière Y; Neutel JM; Davidai G; Koval S
Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
[TBL] [Abstract][Full Text] [Related]
12. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
13. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
[TBL] [Abstract][Full Text] [Related]
14. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring.
Herpin D; Conte D
J Hum Hypertens; 1989 Jun; 3 Suppl 1():11-5. PubMed ID: 2550634
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients.
Mancia G; Omboni S; Agabiti-Rosei E; Casati R; Fogari R; Leonetti G; Montemurro G; Nami R; Pessina AC; Pirrelli A; Zanchetti A
J Cardiovasc Pharmacol; 2000 Jun; 35(6):926-31. PubMed ID: 10836728
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
[TBL] [Abstract][Full Text] [Related]
18. Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension.
Pool JL; Gennari J; Goldstein R; Kochar MS; Lewin AJ; Maxwell MH; McChesney JA; Mehta J; Nash DT; Nelson EB
J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S36-42. PubMed ID: 2442550
[TBL] [Abstract][Full Text] [Related]
19. Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects.
Norton GR; Woodiwiss AJ; Hartford C; Trifunovic B; Middlemost S; Lee A; Allen MJ
Am J Hypertens; 1999 Jun; 12(6):563-71. PubMed ID: 10371365
[TBL] [Abstract][Full Text] [Related]
20. Lisinopril: dose-peak effect relationship in essential hypertension.
Cirillo VJ; Gomez HJ; Salonen J; Salonen R; Rissanen V; Bolognese JA; Nyberg R; Kristianson K
Br J Clin Pharmacol; 1988 May; 25(5):533-8. PubMed ID: 2841960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
